Этот веб-сайт требует, чтобы для Вашего браузера был включен JavaScript.
Пожалуйста, включите JavaScript и перезагрузите страницу.
Для веб-сайта требуется, чтобы Ваш браузер разрешил использование файлов cookie для входа в систему.
Пожалуйста, активируйте cookies и перезагрузите страницу.
Carte romana
Carte rusa
Carte engleza
Vezi toate cartile
Top branduri cosmetica
Cosmetica Coreeana
Machiaj
Ingrijire ten
Ingrijire par
Ingrijire corp
Produse de baie
Igiena orala
Igiena intima
Igiena sexuala
Cosmetice barbati
Seturi cadou
Naturale si organice
Vezi toate cosmeticele
Top branduri dermatocosmetica
Protectie solara
Seturi cadou si pachete promo
Parfumuri pentru femei
Top branduri femei
Premium brands femei
Parfumuri unisex
Vezi toate parfumurile
Parfumuri pentru barbati
Top branduri barbati
Premium brands barbati
Jucarii si jocuri
Hrana si articole copii
Scutece si servetele
Rechizite si papetarie
Vezi toate produsele
Nutritie & Suplimente
Branduri
Certificate Cadou
Felicitari
Plicuri
Cutii si Accesorii
Richard SilvermanOrganic Chemistry of Drug Design and Drug Action, Hardcover
в Пункте приема от 99,9 лей
Даже распечатанный
Перед оплатой
The Organic Chemistry of Drug Design and Drug Action, Third Edition, represents a unique approach to medicinal chemistry based on physical organic chemical principles and reaction mechanisms that rationalize drug action, which allows the reader to extrapolate those core principles and mechanisms to many related classes of drug molecules. This new edition reflects significant changes in the process of drug design over the last decade. It preserves the successful approach of the previous editions while including significant changes in format and coverage.New to this edition: Updates to all chapters, including new examples and referencesChapter 1 (Introduction): Completely rewritten and expanded as an overview of topics discussed in detail throughout the bookChapter 2 (Lead Discovery and Lead Modification): Sections on sources of compounds for screening including library collections, virtual screening, and computational methods, as well as hit-to-lead and scaffold hopping; expanded sections on sources of lead compounds, fragment-based lead discovery, and molecular graphics; and deemphasized solid-phase synthesis and combinatorial chemistryChapter 3 (Receptors): Drug-receptor interactions, cation-p and halogen bonding; atropisomers; case history of the insomnia drug suvorexantChapter 4 (Enzymes): Expanded sections on enzyme catalysis in drug discovery and enzyme synthesisChapter 5 (Enzyme Inhibition and Inactivation): New case histories: for competitive inhibition, the epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib and Abelson kinase inhibitor, imatinibfor transition state analogue inhibition, the purine nucleoside phosphorylase inhibitors, forodesine and DADMe-ImmH, as well as the mechanism of the multisubstrate analog inhibitor isoniazidfor slow, tight-binding inhibition, the dipeptidyl peptidase-4 inhibitor, saxagliptinChapter 7 (Drug Resistance and Drug Synergism): This new chapter includes topics taken from two chapters in the previous edition, with many new examplesChapter 8 (Drug Metabolism): Discussions of toxicophores and reactive metabolitesChapter 9 (Prodrugs and Drug Delivery Systems): Discussion of antibody-drug conjugates
Мы хотели бы узнать Ваше мнение! Оценить и пересмотреть этот пункт
Нет ни одного отзыва от других пользователей.